Tiny molecules may hold key to better care for Opioid-Exposed newborns
NCT ID NCT05937594
First seen Feb 02, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study looks at small molecules called microRNAs in the saliva of newborns exposed to opioids before birth. Researchers want to see if these molecules can help predict how much medicine a baby needs and how they develop over time. The goal is to find simple, non-invasive markers that could lead to more personalized care for babies with neonatal abstinence syndrome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL ABSTINENCE SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Penn State Milton S. Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.